News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
568,585 Results
Type
Article (39027)
Company Profile (84)
Press Release (529474)
Section
Business (174512)
Career Advice (2175)
Deals (28726)
Drug Delivery (88)
Drug Development (61847)
Employer Resources (145)
FDA (13894)
Job Trends (12597)
News (285363)
Policy (27049)
Tag
Academia (2182)
Alliances (44919)
Alzheimer's disease (1112)
Approvals (13906)
Artificial intelligence (187)
Bankruptcy (264)
Best Places to Work (9938)
Breast cancer (196)
Cancer (1445)
Cardiovascular disease (108)
Career advice (1832)
CAR-T (103)
Cell therapy (314)
Clinical research (49187)
Collaboration (597)
Compensation (184)
COVID-19 (2631)
C-suite (141)
Data (1354)
Diabetes (181)
Diagnostics (6447)
Earnings (72451)
Employer resources (131)
Events (84824)
Executive appointments (477)
FDA (14635)
Funding (495)
Gene therapy (209)
GLP-1 (554)
Government (3914)
Healthcare (15497)
Infectious disease (2749)
Inflammatory bowel disease (98)
Interviews (394)
IPO (13003)
Job creations (3079)
Job search strategy (1545)
Layoffs (380)
Legal (6702)
Lung cancer (209)
Manufacturing (209)
Medical device (10600)
Medtech (10604)
Mergers & acquisitions (16042)
Metabolic disorders (452)
Neuroscience (1453)
NextGen: Class of 2025 (5263)
Non-profit (3792)
Northern California (1628)
Obesity (243)
Opinion (220)
Patents (135)
People (47387)
Phase I (15124)
Phase II (21208)
Phase III (17066)
Pipeline (646)
Postmarket research (2178)
Preclinical (6405)
Radiopharmaceuticals (228)
Rare diseases (258)
Real estate (4852)
Regulatory (17923)
Research institute (1999)
Resumes & cover letters (336)
Southern California (1386)
Startups (2869)
United States (14720)
Vaccines (719)
Weight loss (176)
Date
Today (51)
Last 7 days (521)
Last 30 days (2258)
Last 365 days (28138)
2025 (3768)
2024 (28638)
2023 (32567)
2022 (42847)
2021 (46331)
2020 (45275)
2019 (38438)
2018 (28967)
2017 (27348)
2016 (26755)
2015 (31393)
2014 (25870)
2013 (22256)
2012 (22969)
2011 (23242)
2010 (21835)
Location
Africa (835)
Arizona (150)
Asia (32514)
Australia (5649)
California (3656)
Canada (1392)
China (289)
Colorado (182)
Connecticut (212)
Europe (77145)
Florida (560)
Georgia (139)
Illinois (363)
Indiana (210)
Japan (110)
Maryland (620)
Massachusetts (2799)
Michigan (196)
Minnesota (245)
New Jersey (1156)
New York (1099)
North Carolina (725)
Northern California (1628)
Ohio (142)
Pennsylvania (836)
South America (1055)
Southern California (1386)
Texas (545)
Utah (125)
Washington State (355)
568,585 Results for "chiron corporation now novartis vaccines and diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Patents
Novartis Scrambles to Squelch Copycats as Generics Gain Ground
Novartis is locked in a legal back-and-forth with MSN Pharma over alleged patent infringement of its heart failure drug Entresto.
January 17, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Novartis Bets Up to $3.1B to Buy Back Blood Thinner in Anthos Acquisition
Novartis is paying $925 million upfront to acquire Anthos Therapeutics, whose launch the pharma backed in February 2019.
February 11, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Novartis Cuts MorphoSys Sites in Boston, Munich, Affecting 330 Jobs
The closures follow Novartis’s acquisition of MorphoSys earlier this year.
December 19, 2024
·
1 min read
·
Annalee Armstrong
Press Releases
Alzheimer’s Diagnostic Blood Test Now Available in the UK
November 18, 2024
·
1 min read
Legal
GSK Settles Zantac Lawsuits for $2.2B, Analysts Now Shift Focus to Vaccines
The settlement, which is at the low end of Jefferies analysts’ $2 billion to $3.5 billion estimate, will resolve 93% of the product liability cases regarding allegations that GSK’s heartburn drug could cause cancer. Analysts say separate concerns remain about its vaccines business.
October 10, 2024
·
2 min read
·
Tristan Manalac
Vaccines
FDA Issues Back-to-Back Vaccine Approvals as RFK Jr. Takes HHS Seat
The approvals come as Robert F. Kennedy Jr.—who has been critical of vaccines—takes leadership of the Department of Health and Human Services.
February 17, 2025
·
2 min read
·
Tristan Manalac
Earnings
Novartis Eyes More Bolt-On Deals in 2025 as Q4 Earnings Easily Beat Consensus
Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.
January 31, 2025
·
2 min read
·
Tristan Manalac
Business
Chiron AS Establishes State-of-the-Art Research Centre in Trondheim, Norway, Advancing Environmental Surveillance
Chiron AS, a leading producer of chemical reference materials headquartered in Trondheim, Norway, is pleased to announce the establishment of a state-of-the-art research centre dedicated to the enhanced surveillance of environmental pollutants.
January 17, 2024
·
2 min read
Vaccines
5 Late-Stage mRNA Vaccines to Watch
The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the market for cancer, influenza and more.
September 16, 2024
·
5 min read
·
Ben Hargreaves
Legal
Novartis Loses Appeal to Bar Entresto Generic From U.S. Market
Novartis is seeking to prevent the entry of generics for its blockbuster heart failure drug Entresto, its top-selling asset that brought in more than $6 billion in net global sales last year.
December 5, 2024
·
2 min read
·
Tristan Manalac
1 of 56,859
Next
